NUNZIA PHARMACEUTICAL Co — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$0

Net Income/Loss (FY2021)

-$78.1M

Total Assets (FY2021)

$5.1K

Total Equity (FY2021)

-$94.2K

Cash Flows from Operating Activities (FY2021)

-$86.8K

Source: NUNZIA PHARMACEUTICAL Co 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.